Life Science Partner recruited Rachael Fleurence, PhD, to serve as the MDIC’s Executive Director, Coordinating Center in partnership with the National Evaluation System for Health Technology (NEST).
MDIC is the first-ever public-private partnership (PPP) created with the sole objective of advancing medical device regulatory science. MDIC is a nonprofit 501(c)3 organization that operates in partnership with the FDA to improve the medical technology environment. The U.S. Food and Drug Administration (FDA) has awarded the MDIC $3 million in seed funding to establish the Coordinating Center for the Medical Device National Evaluation System for health Technology (NEST).
While at PCORI, Fleurence lead the launch of PCORnet, a national patient centered research network consisting of 130 institutions and patient groups nationwide. She also directed the Clinical Research Methods program in areas including comparative effectiveness research, methods for patient engagement and research prioritization and analytical methodologies.
“The initial phase of the NEST project will include demonstration projects piloting methods for tracking medical device data and patient-reported outcomes through the use of real-world evidence., Fleurence has the unique capability to lead the vision and execution of the MDIC’s Coordinating Center in partnership with NEST,” states Tom Callaway, MD, Founder of Life Science Partner.
Rachael Fleurence earned her Bachelor of Arts Degree in Social and Political Science from University of Cambridge, UK, and her MA in business management from ESSEC- Paris. She completed her Master of Science and PhD in health economics from the University of York. She also completed her AMIA 10X10 Bioinformatics Certificate from the Oregon Health and Sciences University.